Nimawat Herbals Private Limited
This company deals in a wide range of ayurvedic, homeopathic, and pharmaceutical products.
2017 | Rajkot, Gujarat (India) | Active
Nimawat Herbals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Profit Growth -727.52%
- Ebitda -443.30%
- Net Worth -342.20%
- Total Assets 3.36%
About Nimawat Herbals
Nimawat Herbals Private Limited (NHPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 July 2017 (Seven years and seven months 4 days old ). Its registered office is in Rajkot, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashok Nimawat and Divya Nimawat serve as directors at the Company.
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U15125GJ2017PTC098428
- Company No.
098428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jul 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Healthcare
Who are the key members and board of directors at Nimawat Herbals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Nimawat  | Director | 26-Jul-2017 | Current |
| Divya Nimawat | Director | 26-Jul-2017 | Current |
Financial Performance of Nimawat Herbals.
Nimawat Herbals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 727.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 342.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nimawat Herbals?
Unlock access to Nimawat Herbals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nimawat Herbals?
Unlock and access historical data on people associated with Nimawat Herbals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nimawat Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nimawat Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.